
|Slideshows|September 26, 2017
A New Drug in Development for Negative Symptoms
Author(s)Brian Miller, MD, PhD, MPH
Is an effective, well-tolerated treatment for the negative symptoms of schizophrenia on the horizon?
Advertisement
View the slides in PDF format.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
New Phase 3 Clinical Vocal Biomarker Data on Brilaroxazine to Treat Negative Symptoms in Schizophrenia
2
FDA Accepts Investigational New Drug Application for COMP360 for PTSD
3
Accident, or Is It? The Watershed Area Between Trauma and Suicide
4
FDA Grants Breakthrough Therapy Designation to Alixorexton for the Treatment of Narcolepsy Type 1
5

















